UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Alzheimer's & dementia, 2023-12, Vol.19 (S17), p.n/a

2023

Volltextzugriff (PDF)

Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

Alzheimer's & dementia, 2023-11, Vol.19 (11), p.5129-5137

2023

Volltextzugriff (PDF)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome

Cerebral cortex (New York, N.Y. 1991), 2023-08, Vol.33 (16), p.9639-9651

2023

Volltextzugriff (PDF)

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsResearch in context

EBioMedicine, 2023-08, Vol.94, p.104692

2023

Volltextzugriff (PDF)

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels

EBioMedicine, 2023-08, Vol.94, p.104692-104692, Article 104692

2023

Volltextzugriff (PDF)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Journal of neurodevelopmental disorders, 2021-12, Vol.13 (1), p.1-48, Article 48

2021

Volltextzugriff (PDF)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5789-5789

2021

Volltextzugriff (PDF)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5766-5788

2021

Volltextzugriff (PDF)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome

Journal of clinical medicine, 2021-04, Vol.10 (9), p.1882

2021

Volltextzugriff (PDF)

Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome

Alzheimer's & dementia, 2021-04, Vol.17 (4), p.595-604

2021

Volltextzugriff (PDF)

Moral concerns and personal beliefs regarding tax evasion: Empirical results from Germany, Romania, Turkey, and the United Kingdom

Behavioural Public Finance, 2021, Vol.1, p.178-196

1, 2021

Volltextzugriff (PDF)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome

JAMA network open, 2020-09, Vol.3 (9), p.e2018221-e2018221

2020

Volltextzugriff (PDF)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Journal of neurodevelopmental disorders, 2020-01, Vol.12 (1), p.4-4, Article 4

2020

Volltextzugriff (PDF)

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Alzheimer's & dementia, 2019-09, Vol.15 (9), p.1238-1239

2019

Volltextzugriff (PDF)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

Journal of neurodevelopmental disorders, 2019-08, Vol.11 (1), p.20-20, Article 20

2019

Volltextzugriff (PDF)

O4‐03‐05: LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER'S DISEASE IN DOWN SYNDROME

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_24), p.P1236-P1237

2019

Volltextzugriff (PDF)

LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER’S DISEASE IN DOWN SYNDROME

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P1236-P1237

2019

Volltextzugriff (PDF)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

Cerebral cortex (New York, N.Y. 1991), 2019-05, Vol.29 (5), p.2279-2290

2019

Volltextzugriff (PDF)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Frontiers in psychiatry, 2019-04, Vol.10, p.158-158

2019

Volltextzugriff (PDF)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

Alzheimer's research & therapy, 2019-03, Vol.11 (1), p.26-26, Article 26

2019

Volltextzugriff (PDF)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

JAMA neurology, 2019-02, Vol.76 (2), p.152

2019

Volltextzugriff (PDF)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Alzheimer's & dementia, 2019-02, Vol.15 (2), p.245-257

2019

Volltextzugriff (PDF)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

Frontiers in psychology, 2019-01, Vol.9, p.2730-2730

2019

Volltextzugriff (PDF)

P2‐119: DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_13), p.P714-P715

2018

Volltextzugriff (PDF)

O1‐08‐02: SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_4), p.P235-P236

2018

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsResearch in context

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome

Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome

Moral concerns and personal beliefs regarding tax evasion: Empirical results from Germany, Romania, Turkey, and the United Kingdom

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

O4‐03‐05: LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER'S DISEASE IN DOWN SYNDROME

LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER’S DISEASE IN DOWN SYNDROME

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

P2‐119: DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

O1‐08‐02: SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

Suchergebnisse filtern